Despite low cfDNA abundance, CSF NGS and LPWGS provide informative data across neuro-oncologic indications and further work is underway to optimize the assays for low input CSF cfDNA.
C. Riviere-Cazaux, Rahul Kumar, Julian S. Rechberger et al.· Journal of Neuro-Oncology· 0 citations
This position article synthesizes key barriers in ICI therapy while highlighting emerging opportunities to refine patient selection, improve safety, and enhance therapeutic durability, position the field to move beyond the current plateau toward a more precise, effective, and patient-centered era of immuno-oncology.
Joud Hajjar, B. Stephen, A. Aaroe et al.· Journal of Immunotherapy and...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.